Data / Drug companies / Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp.: 6 products in the FDA NDC directory, labeler code 69806
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Merck Sharp & Dohme Corp. (labeler code 69806) lists 6 products in the FDA National Drug Code Directory. By type: 4 bulk ingredients, 2 licensed vaccine bulk intermediate. Its main marketing category is export only. The newest product started marketing on August 24, 2015.
The request: Watch Merck Sharp & Dohme Corp. (FDA labeler code 69806): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 69806
- Products in commercial distribution
- 6
- Packages
- 6
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- November 21, 2001
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Export only | 6 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 4 | 66.7% |
| Licensed vaccine bulk intermediate | 2 | 33.3% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 3 | 50% |
| Liquid | 2 | 33.3% |
| Injection, powder, lyophilized, for solution | 1 | 16.7% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Cilastatin sodium | 69806-0094 | Powder | Export only | August 24, 2015 |
| Imipenem | 69806-0093 | Powder | Export only | August 24, 2015 |
| Caspofungin acetate | 69806-0092 | Injection, powder, lyophilized, for solution | Export only | August 24, 2015 |
| Hepatitis b virus subtype adw hbsag surface protein antigen | 69806-0002 | Liquid | Export only | June 10, 2015 |
| Haemophilus influenzae type b capsular polysaccharide meningococcal outer membrane protein conjugate antigen | 69806-0001 | Liquid | Export only | June 10, 2015 |
| Ertapenem sodium | 69806-0003 | Powder | Export only | November 21, 2001 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.